IκBζ: an emerging player in cancer

Oncotarget. 2016 Oct 4;7(40):66310-66322. doi: 10.18632/oncotarget.11624.

Abstract

IκBζ, an atypical member of the nuclear IκB family of proteins, is expressed at low levels in most resting cells, but is induced upon stimulation of Toll-like/IL-1 receptors through an IRAK1/IRAK4/NFκB-dependent pathway. Like its homolog Bcl3, IκBζ can regulate the transcription of a set of inflamatory genes through its association with the p50 or p52 subunits of NF-κB. Long studied as a key component of the immune response, IκBζ emerges as an important regulator of inflammation, cell proliferation and survival. As a result, growing evidence support the role of this transcription factor in the pathogenesis number of human hematological and solid malignancies.

Keywords: IκBζ; NF-κB pathway; cancer; nuclear IκB protein; perspectives.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • I-kappa B Proteins / genetics
  • I-kappa B Proteins / metabolism*
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / pathology*

Substances

  • I-kappa B Proteins